Sriraman Devarajan Selected Research

Obesity

1/2022	Circulating levels of urocortin neuropeptides are impaired in children with overweight.
1/2022	Salivary Biomarkers as Predictors of Obesity and Intermediate Hyperglycemia in Adolescents.
10/2020	Mediation effect of C-reactive protein in the relationship between abdominal obesity and intermediate hyperglycemia in Kuwaiti adolescents.
1/2020	Spexin as an indicator of beneficial effects of exercise in human obesity and diabetes.
12/2018	Fetuin-A levels are increased in the adipose tissue of diabetic obese humans but not in circulation.
1/2018	Caveolin-1 Variant Is Associated With the Metabolic Syndrome in Kuwaiti Children.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sriraman Devarajan Research Topics

Disease

6	Obesity 01/2022 - 01/2018
5	COVID-19 04/2024 - 04/2021
3	Diabetic Nephropathies (Diabetic Nephropathy) 09/2023 - 01/2019
3	Inflammation (Inflammations) 01/2023 - 01/2015
3	Overweight 01/2022 - 01/2019
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2018
3	Type 2 Diabetes Mellitus (MODY) 01/2020 - 12/2018
2	Metabolic Diseases (Metabolic Disease) 01/2023 - 01/2020
2	Albuminuria 11/2022 - 01/2022
2	Morbid Obesity 01/2022 - 01/2020
2	Hyperglycemia 01/2022 - 10/2020
2	Abdominal Obesity 10/2020 - 01/2018
2	Airway Remodeling 01/2016 - 01/2015
2	Asthma (Bronchial Asthma) 01/2016 - 01/2015
1	Obstructive Sleep Apnea 01/2024
1	Sleep Deprivation 01/2023
1	Kidney Diseases (Kidney Disease) 11/2022
1	Ischemic Stroke 07/2022
1	Thrombocytopenia (Thrombopenia) 07/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Prediabetic State (Prediabetes) 10/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Insulin Resistance 01/2019

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2015
5	CytokinesIBA 04/2024 - 01/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2024 - 01/2015
3	NeuropeptidesIBA 01/2022 - 01/2020
3	UrocortinsIBA 01/2022 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 01/2018
2	Oxygen (Dioxygen)IBA 04/2024 - 05/2023
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 01/2015
2	CreatinineIBA 11/2022 - 01/2022
2	ChemokinesIBA 01/2019 - 01/2015
2	Caveolin 1IBA 01/2019 - 01/2018
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2016 - 01/2015
1	AdiponectinIBA 01/2023
1	Interleukin-8 (Interleukin 8)IBA 01/2023
1	LeptinIBA 01/2023
1	Insulin-Like Growth Factor Binding Protein 1IBA 11/2022
1	Insulin-Like Growth Factor Binding Protein 3IBA 11/2022
1	Insulin-Like Growth Factor Binding Protein 4IBA 11/2022
1	COVID-19 VaccinesIBA 07/2022
1	Prothrombin (Factor II)IBA 07/2022
1	BNT162 VaccineIBA 07/2022
1	AntithrombinsIBA 07/2022
1	Blood Coagulation Factors (Coagulation Factor)IBA 07/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Cadherins (E-Cadherin)IBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 04/2021
1	C-Reactive ProteinIBA 10/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Chemokine CCL19IBA 01/2019
1	alpha-2-HS-GlycoproteinIBA 12/2018
1	HDL CholesterolIBA 01/2018
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2015
1	Chemokine CX3CL1IBA 01/2015
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2015
1	Interleukin-10 (Interleukin 10)IBA 01/2015
1	platelet-derived growth factor AIBA 01/2015
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2015
1	Monocyte Chemoattractant ProteinsIBA 01/2015

Therapy/Procedure

2	Bariatric Surgery 01/2022 - 01/2020
1	Toothbrushing 01/2022
1	Gastrectomy 01/2020
1	Resistance Training 01/2019